共 14 条
[1]
Preparation and characterization of solid lipid nanospheres containing paclitaxel. Cavalli R,Caputo O,Gasco MR. European Journal of Pharmaceutical Sciences . 2000
[2]
Efficient conversion of cephalomannine to paclitaxel and 3 ’ -N-Acyl-3 ’ -N-debenzoylpaclitaxel Analogs. AA Leslie G,Mahendra DC,David GIK. Journal of Organic Chemistry . 1997
[3]
Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel ( Taxol ). Feng SS,Mu L,Chen BH,Pack D. Materials Science and Engineering . 2002
[4]
Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Liggins RT,Burt HM. Advanced Drug Delivery Reviews . 2002
[5]
Solubility and stability of taxol: effects of buffers and cyclodextrins. Dordunoo SK,Burt HM. International Journal of Pharmaceutics . 1996
[6]
A novel controlled release formulation for the anticancer drug paclitaxel ( Taxol ) : PLGA nanoparticles containing vitamin E TPGS. Mu L,Feng SS. Journal of Controlled Release . 2003
[7]
A Facile N-Debenzoylation of Paclitaxel: Conversion of Paclitaxel to Docetaxel. Prakash GJ,David GIK. Tetrahedron Letters . 1999
[8]
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. Kim SC,Kim DW,Shim YH,et al. Journal of Controlled Release . 2001
[9]
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. Zentner GM,Rathi R,Shih C,et al. Journal of Controlled Release . 2001
[10]
A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. Lundberg BB,Risovic V,Ramaswamy M,et al. Journal of Controlled Release . 2003